The global Maternal and Infant Probiotics market size is predicted to grow from US$ 6504 million in 2025 to US$ 10920 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.

Maternal and infant probiotics refer to probiotic supplements designed for mothers, infants and young children. These products contain active microorganisms that are beneficial to maternal and infant health, aiming to promote digestive health, enhance immunity, and prevent or reduce allergic symptoms by regulating the balance of intestinal flora. Maternal and infant probiotic products are often specially formulated to ensure safety and suitability for use by the mother during pregnancy and lactation, and for the infant and young child during their early development.

United States market for Maternal and Infant Probiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Maternal and Infant Probiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Maternal and Infant Probiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Maternal and Infant Probiotics players cover Bayer Corporation, Nestle S.A, Mommys Bliss Inc, LoveBug Probiotics, BioGaia AB, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the Maternal and Infant Probiotics Industry Forecast looks at past sales and reviews total world Maternal and Infant Probiotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Maternal and Infant Probiotics sales for 2025 through 2031. With Maternal and Infant Probiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Maternal and Infant Probiotics industry.

This Insight Report provides a comprehensive analysis of the global Maternal and Infant Probiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Maternal and Infant Probiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Maternal and Infant Probiotics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Maternal and Infant Probiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Maternal and Infant Probiotics.

This report presents a comprehensive overview, market shares, and growth opportunities of Maternal and Infant Probiotics market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Powder
    Liquid
    Soft Candy

Segmentation by Application:

    Hospital
    Clinic
    Supermarkets
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Bayer Corporation
    Nestle S.A
    Mommys Bliss Inc
    LoveBug Probiotics
    BioGaia AB
    MaryRuth Organics
    Infinant Health
    Biomeology
    Nordic Naturals
    Culturelle
    Life-Space
    Witsbb
    Biostime
    BY-health

Key Questions Addressed in this Report

What is the 10-year outlook for the global Maternal and Infant Probiotics market?
What factors are driving Maternal and Infant Probiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Maternal and Infant Probiotics market opportunities vary by end market size?
How does Maternal and Infant Probiotics break out by Type, by Application?